| # | Drug | Count |
|---|---|---|
| 0 | ADALIMUMAB | 29 |
| 1 | PREDNISONE | 23 |
| 2 | TRASTUZUMAB | 20 |
| 3 | ADALIMUMAB-AATY | 18 |
| 4 | ADALIMUMAB-ADAZ | 18 |
| 5 | ADALIMUMAB-FKJP | 18 |
| 6 | METHOTREXATE SODIUM | 18 |
| 7 | RITUXIMAB | 18 |
| 8 | METHOTREXATE | 16 |
| 9 | METHYLPREDNISOLONE | 13 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | METHENAMINE MANDELATE | 1 | 0.0053 |
| 1 | ILOPROST | 1 | 0.0011 |
| 2 | PYRAZINAMIDE | 8 | 0.0008 |
| 3 | ETHIODIZED OIL | 1 | 0.0008 |
| 4 | POLATUZUMAB VEDOTIN | 7 | 0.0007 |
| 5 | POLIDOCANOL | 1 | 0.0007 |
| 6 | TALIMOGENE LAHERPAREPVEC | 1 | 0.0006 |
| 7 | BACILLUS CALMETTE-GUERIN | 1 | 0.0006 |
| 8 | ISONIAZID | 8 | 0.0005 |
| 9 | RIFAMPIN | 7 | 0.0005 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Sclerosing Agent [EPC] | 1 | 0.0022 |
| 1 | Prostacycline [EPC] | 1 | 0.0011 |
| 2 | Live Attenuated Bacillus Calmette-Guerin Immunotherapy [EPC] | 1 | 0.0006 |
| 3 | Antimycobacterial [EPC] | 9 | 0.0004 |
| 4 | Rifamycin Antimycobacterial [EPC] | 1 | 0.0003 |
| 5 | Antimetabolite Immunosuppressant [EPC] | 6 | 0.0003 |
| 6 | HER2/neu Receptor Antagonist [EPC] | 20 | 0.0003 |
| 7 | Antihypoglycemic Agent [EPC] | 1 | 0.0002 |
| 8 | Rifamycin Antibacterial [EPC] | 7 | 0.0002 |
| 9 | CTLA-4-directed Blocking Antibody [EPC] | 9 | 0.0002 |